Lyell Immunopharma
LYEL
LYEL
105 hedge funds and large institutions have $95.9M invested in Lyell Immunopharma in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
10% less funds holding
Funds holding: 117 → 105 (-12)
34% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 32
46% less capital invested
Capital invested by funds: $177M → $95.9M (-$80.7M)
Holders
105
Holding in Top 10
6
Calls
$11K
Puts
$10K
Top Buyers
| 1 | +$7.62M | |
| 2 | +$5.21M | |
| 3 | +$4.55M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.31M |
| 5 |
Renaissance Technologies
New York
|
+$905K |
Top Sellers
| 1 | -$1.93M | |
| 2 | -$1.91M | |
| 3 | -$1.65M | |
| 4 |
HF
HRT Financial
New York
|
-$785K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$645K |